Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 3Small Cell Lung Carcinoma 2Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Etoposide 34Carboplatin 31Topotecan 24Cisplatin 21atezolizumab 11PM 01183 8durvalumab 7Irinotecan 7amrubicin 5PE regimen 4AMG 757 4rovalpituzumab tesirine 3pembrolizumab 3Magnetic Resonance Spectroscopy 3Dexamethasone 3tremelimumab 2tislelizumab 2etoposide phosphate 2apatinib 2Vitamin E 2Tiragolumab 2Specimen Handling 2Radiosurgery 2RRx-001 2Paclitaxel 2Memantine 2Injections 2EC regimen 2trilaciclib 1toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Small Cell Lung Carcinoma × Tiragolumab × Clear all
NCT04256421 2026-04-03

SKYSCRAPER-02

Hoffmann-La Roche

Phase 3 Completed
490 enrolled 33 charts
Thoracic

Small Cell Lung Carcinoma

NCT04665856 2026-02-13

SKYSCRAPER-02C

Hoffmann-La Roche

Phase 3 Active not recruiting
123 enrolled 26 charts
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡